A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

Clinical trial NCT07101939 · RECRUITING

Trial details

NCT number: NCT07101939
Sponsor: Actimed Therapeutics Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Muscle Loss

Start date: 2025-06-23
Primary completion: 2027-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.